$ATNMStrong rational to combine AWE with Daratumumab.                             Market size 
Alzheimer      13B
cysticfibrosis 14B
Huntington     1B
Sickle  2B
Hemophilia 18B               
COVID19 7B
 $bmy $mrk $mark $abbv $amgn $pfe $nvs @JNJInnovation @JNJCares $jnj @biogen https://t.co/KPo5LiezSF